-

NYSE to Suspend Trading Immediately in Warrants of Blue Owl Capital Inc. (OWL WS) and Commence Delisting Process

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to delist the warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share, of Blue Owl Capital Inc. (the “Company”) — ticker symbol OWL WS — from the NYSE. Trading in the Company’s warrants will be suspended immediately. Trading in the Company’s Class A common stock — ticker symbol OWL — will continue on the NYSE.

NYSE Regulation reached its decision to delist the warrants of the Company pursuant to Section 802.01D of the NYSE Listed Company Manual because the warrants no longer meet the minimum distribution criteria after the partial redemption of the warrants as described in the Company’s July 18, 2022 disclosure.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the warrants pending completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contact:
Investor Contact
Ann Dai
Head of Investor Relations
blueowlir@blueowl.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contact:
Investor Contact
Ann Dai
Head of Investor Relations
blueowlir@blueowl.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol RBOT WS — thirty (30) whole warrants are exercisable to purchase one share of Class A common stock of Vicarious Surgical Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company’s Class A common stock — tick...

NYSE to Commence Delisting Proceedings with Respect to Warrants of BARK, Inc. (BARK WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol BARK WS — each exercisable for one share of common stock of BARK, Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company’s common stock — ticker symbol BARK — will continue on the NYSE. NYSE Regulation has...

NYSE Group Consolidated Short Interest Report

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of November 28, 2025. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 11/28/2025 NYSE 16,304,706,833 15,965,725,933 2,883 2,544 11/28/2025 NYSE ARCA 2,169,387,274 2,195,232,534 2,496 1,693 11/28/2025 NYSE AMERICAN 776,609,642 792,768,249 298...
Back to Newsroom